aTyr Pharma Obtains $23,000,000 Series C Financing

  • Feed Type
  • Date
    10/26/2010
  • Company Name
    aTyr Pharma
  • Mailing Address
    3565 General Atomics Court San Diego, CA 92121
  • Company Description
    We have developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts.
  • Website
    http://www.atyrpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds will be used to accelerate the development of aTyr’s preclinical pipeline and advance physiocrine drug candidates into clinical trials.
  • M&A Terms
  • Venture Investor
    Domain Associates
  • Venture Investor
    Alta Partners
  • Venture Investor
    Cardinal Partners
  • Venture Investor
    Polaris Venture Partners

By posting a comment, you agree to our terms and conditions.